An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosu
International audienceAutoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid art...
Systemic lupus erythematosus (SLE) is a rheumatologic disease characterized by an inflammatory destr...
The incidence of antibodies to Epstein‐Barr nuclear antigen type 2 (EBNA‐2) was determined in sera f...
Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patient
The immune responses to antigens from different stages of the Epstein–Barr virus (EBV) life cycle we...
Infections may act as environmental triggers for the induction of systemic lupus erythematosus (SLE)...
We analyzed cytokine responses against latent and lytic Epstein-Barr virus (EBV) antigens in systemi...
Systemic lupus erythematosus (SLE or lupus) is a complex disease with a multifactoral etiology, with...
Objectives Clinical and laboratory investigations have revealed that Epstein-Barr virus (EBV) is inv...
Previous studies showed a link between systemic lupus erythematosus (SLE) and Epstein-Barr virus (EB...
INTRODUCTION: Systemic lupus erythematosus is characterized by production of autoantibodies to RNA o...
This study was aimed to evaluate the role of B-cell epitopes of Epstein–Barr virus (EBV) Early antig...
rheumatoid arthritis, and a variable but lesser per-centage of normal subjects, have precipitating a...
SmD is one of the small nuclear ribonucleoproteins frequently targeted by autoantibodies in systemic...
SmD is one of the small nuclear ribonucleoproteins frequently targeted by autoantibodies in systemic...
International audienceAutoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid art...
Systemic lupus erythematosus (SLE) is a rheumatologic disease characterized by an inflammatory destr...
The incidence of antibodies to Epstein‐Barr nuclear antigen type 2 (EBNA‐2) was determined in sera f...
Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patient
The immune responses to antigens from different stages of the Epstein–Barr virus (EBV) life cycle we...
Infections may act as environmental triggers for the induction of systemic lupus erythematosus (SLE)...
We analyzed cytokine responses against latent and lytic Epstein-Barr virus (EBV) antigens in systemi...
Systemic lupus erythematosus (SLE or lupus) is a complex disease with a multifactoral etiology, with...
Objectives Clinical and laboratory investigations have revealed that Epstein-Barr virus (EBV) is inv...
Previous studies showed a link between systemic lupus erythematosus (SLE) and Epstein-Barr virus (EB...
INTRODUCTION: Systemic lupus erythematosus is characterized by production of autoantibodies to RNA o...
This study was aimed to evaluate the role of B-cell epitopes of Epstein–Barr virus (EBV) Early antig...
rheumatoid arthritis, and a variable but lesser per-centage of normal subjects, have precipitating a...
SmD is one of the small nuclear ribonucleoproteins frequently targeted by autoantibodies in systemic...
SmD is one of the small nuclear ribonucleoproteins frequently targeted by autoantibodies in systemic...
International audienceAutoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid art...
Systemic lupus erythematosus (SLE) is a rheumatologic disease characterized by an inflammatory destr...
The incidence of antibodies to Epstein‐Barr nuclear antigen type 2 (EBNA‐2) was determined in sera f...